Alliance Healthcare
Alliance Healthcare Group Limited is an integrated healthcare group that leverages the use of technology to provide a broad suite of healthcare services primarily in Singapore. The Group designs and provides enterprise-level healthcare solutions to meet the demands of organisations as well as individual patients for reliable and cost-effective healthcare services.
1HFY21 Results Announcement
Est 15 Feb 2021
SGX 10 In 10
FY2020 FAQ
Recent Developments
-
25 Feb 21
-
9 Feb 21
-
7 Jan 21
-
7 Jan 21
-
7 Jan 21
-
5 Jan 21
-
23 Dec 20
-
28 Oct 20
-
28 Oct 20
-
26 Oct 20
-
13 Oct 20
-
13 Oct 20
-
13 Oct 20
-
30 Sep 20
-
10 Sep 20
-
8 Sep 20
-
Riding on the tailwinds of a growing defensive healthcare industry.
-
One of the largest managed healthcare service provider in Singapore
-
High barriers to entry for the growing managed healthcare segment, due to high capital investments to establish a sizable network of medical services providers as well as investments in IT systems.
-
Tapping on the increased demand for mobile healthcare via Jaga-me
-
Healthy balance sheet with positive cash flow generation.
-
Founders’ interests are aligned with shareholders. The Group has also expressed their intention to distribute at least 30% of its net profits for FY20 and FY21 as dividends to shareholders.
- Alliance Healthcare wins contract to provide healthcare services to 38 firms
- Alliance Healthcare partners Inova Care to explore opportunities in the region
- Alliance Healthcare focuses on affordable and accessible clinics; banks on telemedicine
- Alliance leverages tech to provide broad suite of healthcare service
- Alliance expands in managed healthcare
- Alliance Healthcare sees 631.5% surge in earnings in first year since listing
- Alliance Healthcare and DBS to collaborate on marketing activities
- Alliance Healthcare partners DBS to provide health and wellness programme to DBS insurance policyholders
- Alliance Healthcare Stock Review – 4 Reasons To Like About This Defensive Healthcare Company
- Building back in a post-pandemic world
| Brokerages/Blog | Report | Analysts | Recommendation | TP |
|---|---|---|---|---|
| RHB | Top 20 jewels of 2020 | Lee Cai Ling | Non-Rated | N/A |
| Smallcapasia | 4 Reasons To Like About This Defensive Healthcare Company | Smallcapasia | Non-Rated | N/A |
| Price | 0.180 |
|---|---|
| Market Cap (SGDm) | 37.4 |
| YE | 06/2021 |
| Earnings Release Date (Est) | 15/02/2021 |
| 52 wk high/low | 0.20/0.05 |
| YTD % change | 0% |
| Free Float % | 15.6% |
| Key Highlights | 2018 | 2019 | 2020 |
|---|---|---|---|
| Revenue (SGDm) | 33.8 | 36.5 | 42.8 |
| Net Profit (SGDm) | 3.1 | 0.3 | 2.6 |
| Adjusted Net Profit (SGDm) | 3.1 | 1.6* | 2.3 |
| Adjusted P/E | 12.1 | 24.1 | 16.0 |
| P/B | 5.5 | 2.2 | 1.9 |
| Return on Equity | 49.9% | 4.7% | 15.9% |
| Net D/E | -66.3% | -55.9% | -45.2% |
Loss of key corporate and/or insurance clientele, loss of network of medical professionals, dependent on health of doctors for operation of clinics